The SEC has been a beehive of activity throughout 2019 and into 2020, whether on the rulemaking, interpretive or enforcement fronts that affect the annual report on Form 10-K of many, if not most, calendar-year filers. To help companies now in the final stages of preparing their Form 10-K ensure that they have covered all the line-item bases, we have prepared a checklist in this Alert. This checklist includes a summary of the most recent SEC interpretive guidance relating to disclosure of MD&A/Key Performance Indicators issued on January 30, 2020. For ease of reference, the checklist items appear in the order of the Form 10-K line-item disclosure requirements.
Just Before Filing: A Last Minute Checklist for the 2019 Form 10-K
SEC Staff Brings Down its Q1 COVID-related Reporting Guidance for Q2: Focus on Liquidity and Capital Resources, CARES Act Assistance, Ability to Continue as a Going Concern and High-Quality Financial Reporting
Copyright © 2020 Weil, Gotshal & Manges LLP, All Rights Reserved. The contents of this website may contain attorney advertising under the laws of various states. Prior results do not guarantee a similar outcome. Weil, Gotshal & Manges LLP is headquartered in New York and has office locations in Beijing, Boston, Dallas, Frankfurt, Hong Kong, Houston, London, Miami, Munich, New York, Paris, Princeton, Shanghai, Silicon Valley, and Washington, D.C.